Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management: Our Bureau, Chennai Monday, December 15, 2025, 15:45 Hrs [IST] Akums Drugs & ...
Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...